Diabetes patients who are dependent on lifelong insulin therapy must administer vital medicine to themselves using insulin pumps, syringes, or pens. ypsomed produces a disposable pen, UnoPen ™, with variable dose adjustment, for this and other multidose therapies. Schreiner MediPharm has developed an NFC tag for this injection aid that serves as a communication interface between the injector and SmartPilot ™, an electronic pen plug-in. The resulting smart device interactively supports patients using the pen and helps them meet their therapy plans.
Schreiner MediPharm designed the tag with an integrated NFC chip precisely for the combination of UnoPen ™ and SmartPilot ™. With the NFC tag, the drug can be automatically identified, authenticated and verified in terms of its expiration date.
Thanks to the smart device, the time and date of the injection, as well as the administered dose, are controlled and transmitted to the application of the patient's smartphone via Bluetooth. Patients are guided interactively through the injection process, assisted in the correct use of the pen in real time, or informed of inconsistencies, for example in case of deviations from the therapy plan or accidental attempts to inject twice.
A temperature control function is also built in that issues a warning if the pen has been exposed to high temperatures while in use or storage. Sensor technology installed in the SmartPilot ™ that digitally connects the UnoPen ™ enables this feature.
